Novo Nordisk tackles outcomes and affordability with pilot tying copays to adherence
admin 18th April 2018 Uncategorised 0In a new approach to the pricing and payer issues beleaguering pharma in general and diabetes drugmakers in particular, Novo Nordisk has teamed up on a project that puts patients with diabetes to work earning discounted copays and other incentives
read more